Skip to main content
Journal of Carcinogenesis logoLink to Journal of Carcinogenesis
. 2015 Feb 23;14:2. doi: 10.4103/1477-3163.151965

Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers: Retraction

PMCID: PMC4360551  PMID: 25788867

The article, “Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers” published on page 1-10, Vol 10 of Jan 2011 issue of Journal of Carcinogenesis[1], is being retracted at the request of the University of Maryland, Baltimore. It has been determined that in figures 4 and 5, the western blot bands have been manipulated. Bands have been found to be identical, although claimed to be from different sources and labeled differently. Consequently, the Vice President of Academic Affairs and the Assistant Vice President, Research Integrity have requested the retraction of the article.

Roger J. Ward, EdD, JD, MPA Chief Accountability Officer Vice President of Academic Affairs Vice Dean, Graduate School University of Maryland, Baltimore

Louise Ramm, PhD Assistant Vice President, Research Integrity University of Maryland, Baltimore

REFERENCE

  • 1.Almubarak H, Jones A, Chaisuparat R, Zhang M, Meiller TF, Scheper MA. Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers. J Carcinog. 2011;10:2. doi: 10.4103/1477-3163.75723. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Journal of Carcinogenesis are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES